InMed Pharmaceuticals Inc. (INM)
Follow InMed Pharmaceuticals Inc. (INM) for new congressional filings and notable company-insider purchases. No congressional trades are visible in this view.
- Trades disclosed
- 0
- Members trading
- 0
- Buys / sells
- 0 / 0
- Reported value
- Undisclosed
Keep following the company.
Subscribers get new congressional filings and notable insider purchases for companies they follow. Coverage varies by company.
What else is happening at INM
All research →Company filings and public records connected to this stock, ordered by when they became public or were first observed.
INM: Acquisition or asset disposal · Financial results
Filed 8-K for an event or period dated 2026-11-16. Acquisition or asset disposal; Financial results.
INM: Material agreement · Acquisition or asset disposal · Financial results · Unregistered securities sale · Leadership change
Filed 8-K for an event or period dated 2026-11-06. Material agreement; Acquisition or asset disposal; Financial results; Unregistered securities sale; Leadership change.
INM: ADAR1 Capital Management, LLC; Schneeberger Daniel reported buying shares
1 reported purchase of non-derivative securities. Code P includes open-market and private purchases; it does not establish motive.
INM: Company disclosure
Filed 8-K for an event or period dated 2026-11-09. Company disclosure.
INM: Company disclosure
Filed 8-K for an event or period dated 2026-11-04. Company disclosure.
All trades
From periodic transaction reports filed under the STOCK Act. Amounts are the ranges members report, and trades can be disclosed up to 45 days after they happen. Nothing here is investment advice.